Immunotherapy. 2011 Jan;3(1):13-6. doi: 10.2217/imt.10.97.
The Miniaturisation - Micro Scale Bioprocess Development conference organized by Euroscicon hosted 44 delegates from the UK, Germany and Switzerland. The aim of the meeting was to highlight the recent technologies used in high-throughput bioprocess development, ranging from the selection of clones through to the analysis of the final product and formulation. Expert speakers discussed the development and use of up-to-date miniaturization technologies and the regulatory hurdles that must be overcome to expedite a wider industrial uptake. The meeting was chaired by Gary Lye (University College London, UK). Lye gave a detailed introduction to the meeting, ending with a talk and a summation at the close of the conference.
由 Euroscicon 组织的微型化-微尺度生物工艺开发会议接待了来自英国、德国和瑞士的 44 名代表。会议的目的是强调高通量生物工艺开发中使用的最新技术,从克隆的选择到最终产品和配方的分析。专家演讲者讨论了最新微型化技术的开发和使用,以及为加快更广泛的工业采用而必须克服的监管障碍。会议由 Gary Lye(英国伦敦大学学院)主持。Lye 对会议进行了详细介绍,在会议结束时进行了演讲和总结。